<DOC>
	<DOCNO>NCT03101397</DOCNO>
	<brief_summary>Diffuse Parenchymal Lung Disease ( DPLD ) chronic progressive fibrosis lung disease highly variable clinical process.Krebs von den Lungen-6 ( KL-6 ) high-molecular-weight glycoprotein , classify human MUC1 mucin , produce mainly regenerate type II pneumocytes.Serum level KL-6 show elevated patient DPLD could predict progress , unaware differential threshold . The objective study perspectively sequentially monitor serum KL-6 level patient different DPLD , analyze clinical value find differential threshold .</brief_summary>
	<brief_title>The Clinical Value Serum KL-6 Changes Evaluating Disease Development Different Diffuse Parenchymal Lung Disease</brief_title>
	<detailed_description>Subjects Method : Recruiting different DPLD patient hospital 2013 February 2016 October , include polymyositis/dermatomyositis relate interstitial lung disease ( PM/DM-ILD ) , rheumatoid arthritis relate interstitial lung disease ( RA - ILD ) , interstitial pneumonia autoimmune feature ( IPAF ) idiopathic pulmonary fibrosis ( IPF ) , follow enery 3 6 month . Once condition deteriorate , patient could return time necessary accord clinical physician judgment . Tumor markersï¼Œpulmonary function test ( PFT ) ; chest thin-section CT examination CT score ; serum KL-6 level acquire patient baseline follow-up . Serum KL-6 measure LUMIPULSE G System ( FUJIREBIO , JAPAN ) chemiluminescence enzyme immunoassay . All follow-up patient respectively divide improve , stable deteriotated group accord official ATS/ERS statement . Inclusion criterion : ( 1 ) patient PM/DM-ILD , RA-ILD , IPAF , IPF.The diagnosis patient accord official ATS/ERS statement American College Rheumatology/European League standard ; ( 2 ) 18 80 year old . Exclusion criterion : ( 1 ) conbination pulmonary tubenculersis , pulmonary infection , tumor ; ( 2 ) serum KL-6 pulmonary function test chest thin-section CT examintion ; ( 3 ) patient severe hepatic renal dysfunction , heart disease receive hemodialysis treatment ; ( 4 ) pregnant plan pregnant</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>Clinical diagnosis PM/DMILD , RAILD , IPAF , IPF Combined pulmonary infection , pulmonary tuberculosis , carsinoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>serum KL-6</keyword>
	<keyword>pulmonary function test</keyword>
	<keyword>CT score</keyword>
	<keyword>evaluation</keyword>
</DOC>